Are We on the Verge of a Recession?
Markets are rattled, recession fears rising--but one expert saw it coming. CNBC calls him "The Prophet" for a reason. Whitney Tilson just made a bold new call--one that could change everything. Watch his urgent prediction now in this free video.
Health Insurers Surge After Medicare Agency Increases Payment Rates
Health insurer stocks are trading higher after the market close on Monday following a report indicating the Trump administration will increase payment rates for Medicare insurers.
The skyrocketing cost of weight-loss drugs has state Medicaid programs looking for a solution
States increasingly struggling to of popular GLP-1 drugs like Wegovy, Ozempic and Zepbound are searching for ways to get out from under the budgetary squeeze that took them by surprise.
Warren Buffett's Investing Partner's Shocking Final Move - Ad
Before he passed away, Charlie Munger, Warren Buffett's investing partner of 60 years, was rumored to have quietly made one final investment... Up until now, it has remained hidden from the public. It's potentially the smartest, most profitable, and most under-valued AI investment you can make today.
Weedkiller maker asks US Supreme Court to block lawsuits claiming it failed to warn about cancer
JEFFERSON CITY, Mo. (AP) — Global agrochemical manufacturer Bayer has asked the U.S. Supreme Court to decide whether federal law preempts thousands of state lawsuits alleging it failed to warn people that its popular weedkiller could cause cancer.
That water bottle you're carrying says a lot more than 'hydration'
If you like to stay hydrated no matter where you go, chances are you’ve got a reusable water bottle or two. Or 10. (The collectors know who they are.)
Biggest Dividend Payout in U.S. History: $1 Trillion up for Grabs! - Ad
Trump just launched a $1 trillion National Investment Fund to replace income taxes and send direct payouts to Americans. You could claim up to $21,307--before the first public checks go out. This is historic. Act now to be first in line.
Layoffs threaten US firefighter cancer registry, mine research and mask lab
NEW YORK (AP) — have gutted a small U.S. health agency that aims to protect workers — drawing rebukes from firefighters, coal miners, medical equipment manufacturers and a range of others.
Chemical industry seeks exemptions from US pollution rules as part of Trump administration offer
WASHINGTON (AP) — Industry groups representing hundreds of chemical and petrochemical manufacturers are seeking blanket to reduce emissions of toxic chemicals such as mercury, arsenic and benzene.
Trump to Trigger 3rd Financial Reset - Ad
Markets are falling, prices are rising, and trust is breaking. But a man who has known Trump for years and served as his advisor believes it's not failure--it's a plan. A secret financial reset, decades in the making, is already unfolding...The question is: will you be blindsided--or benefit?
FDA Delays Full Approval Decision On Novavax's COVID-19 Vaccine (UPDATED)
Novavax's COVID-19 vaccine received FDA Emergency Use Authorization, but full approval faces delays as regulators request more data beyond the April 1 deadline.
Truck driver can seek triple damages in lawsuit over THC content in CBD product, Supreme Court says
WASHINGTON (AP) — on Wednesday sided with a truck driver who wants to sue for triple damages over a CBD hemp product he says was falsely advertised as being free from marijuana’s active ingredient and resulted in him getting fired.
Hate Elon? Read Immediately - Ad
Elon Musk is days away from launching the most radical economic transformation in American history. Please understand... you don't have long to act before Elon makes his move. Inside the next 100 days, I predict he's going to instigate an economic transformation that'll impact hundreds of millions of people.
A stroke survivor speaks again with the help of an experimental brain-computer implant
Scientists have developed a device that can translate thoughts about speech into in real time.
The Latest: Countries sending humanitarian aid after Myanmar earthquake
BANGKOK (AP) — The from Myanmar's keeps climbing amid rescue efforts.
Nearly $3 Trillion Gone... - Ad
$3 trillion vanished from the market--but the real shock is still ahead. Whitney Tilson says a little-known executive order could spark a massive economic shift. Most Americans aren't ready. See his urgent 3-step plan--available free for a limited time.
European committee says Lilly Alzheimer's drug shouldn't get marketing approval
A European regulatory committee rejected Eli Lilly’s U.S.-approved over potentially dangerous risks of brain bleeding and swelling.
EPA offers industrial polluters a way to avoid rules on mercury, arsenic and other toxic chemicals
WASHINGTON (AP) — As part of a , the Trump administration is offering coal-fired power plants and other industrial polluters a chance for exemptions from requirements to reduce emissions of toxic chemicals such as mercury, arsenic and benzene.
Volatility Roils the Market -- Here's What to Do Next - Ad
$3 trillion vanished from the market--but the real shock is still ahead. Whitney Tilson says a little-known executive order could spark a massive economic shift. Most Americans aren't ready. See his urgent 3-step plan--available free for a limited time.
Penny Stock Leap Therapeutics Unveils Positive Data From Experimental Combo Therapy For Colorectal Cancer
Leap Therapeutics' Phase 2 trial data show sirexatamab boosts response rates and survival in MSS colorectal cancer, with ongoing business development plans.
Sewage sludge can find a second life on farm fields. Here's how it's made
What goes down your toilet can end up on farm fields across the United States.
AI Bloodbath Coming on June 1st? - Ad
If you're invested in AI stocks, you need to see Elon Musk's new invention. A $2.2 trillion shakeup could hit as soon as June 1--crashing giants like Nvidia. Former hedge fund manager Enrique Abeyta reveals how to prepare.
Finding health advice on social media is easier than knowing which claims to trust
In the corners of social media dominated by wellness content, influencers recommend an assortment of treatments and products to support weight loss, fight exhaustion or promote other desired health outcomes.
North Carolina justices decide family can sue over unwanted COVID-19 shot
RALEIGH, N.C. (AP) — A North Carolina mother and son can sue a public school system and a doctors' group on allegations they gave the boy a COVID-19 vaccine without consent, the state Supreme Court ruled on Friday, reversing a lower-court decision that declared a federal health emergency law blocked the litigation.
Never Pay Taxes Again?!? - Ad
What if your next tax bill was $0--and the government paid you instead? Trump's new $1 trillion plan could replace income taxes with massive dividend checks. Some early investors are already claiming up to $21,307.
If you’re feeling lost at work, speak up. Clarity and feedback can put you on the right path
NEW YORK (AP) — When Nikelle Inman started a new job coaching , she looked forward to meeting with them one-on-one to talk about how to surmount obstacles and .
Novartis New Data From Single-Dose Gene Therapy Shows Meaningful Efficacy, Safety In Patients With Spinal Muscular Atrophy
Novartis' OAV101 IT gene therapy showed positive results in Phase 3 trials for SMA, with data supporting its potential as a treatment option.
Tiny AI Firm Could Outperform NVIDIA - Ad
The Fear & Greed Index shows "extreme fear"--precisely when life-changing wealth is created for those with the right strategy. My elite research team has broken down exactly how to identify the coins with highest rebound potential in this artificially suppressed market.
Purdue Pharma submits opioid lawsuit settlement plan, including up to $7 billion cash from Sacklers
Purdue Pharma asked a bankruptcy judge late Tuesday to consider the latest version of its plan to settle thousands of lawsuits over the toll of the powerful prescription painkiller OxyContin, a deal that would have members of the Sackler family who own the company pay up to $7 billion.
Patient dies following muscular dystrophy gene therapy, Sarepta reports
WASHINGTON (AP) — Sarepta Therapeutics said Tuesday that a patient died while taking its closely watched , sending company shares plummeting in morning trading.
"Trump Will Be Furious We're Leaking This..." - Ad
Bombshell new accusation from Trump insider. Economic advisor, personal friend, and campaign insider breaks silence on the financial crisis he believes is being engineered by the Trump administration.
Eat grass-fed beef, help the planet? Research says not so simple
For cattle fattened in fields instead of feedlots, the grass may be greener, but the carbon emissions are not.
Avidity Biosciences Touts Positive Data From Early-Stage Duchenne Muscular Dystrophy Study Data, FDA Submission Expected By End Of 2025
Avidity's del-zota met key Phase 1/2 trial goals in DMD44, shows strong exon skipping, dystrophin restoration and creatine kinase reduction.
The DOGE Shock: Nine Stocks to Buy - Ad
They say that DOGE's real agenda could shock the entire stock market in the coming days - sending a handful of widely unknown stocks soaring. And they've compiled the definitive investment playbook for anyone who wants the opportunity to capitalize.
Europe Approves Bristol Myers' Cell Therapy Breyanzi For Patients With Certain Type Of Blood Cancer
EC approves BMY's Breyanzi for relapsed or refractory FL, based on Phase 2 study showing high response rates & sustained efficacy.
Home Care Platform Aveanna Healthcare Reports Quarterly Profit, Expects Organic Volume Growth, Enhanced Profitability Into 2025
Aveanna Healthcare posted Q4 EPS of $0.05, beating forecasts, with revenue up 8.6% to $519.9 million. The company expects 2025 revenue of up to $2.12 billion
Elon's Biggest Secret Could Save Your Retirement - Ad
From a near-fatal car crash to surviving deadly malaria, Musk's fearless drive built Tesla, SpaceX, and Starlink. Now, he's warning America--and smart investors are listening. Discover the Trump IRS Loophole to protect your IRA & 401(k).
Merck Plans Regulatory Submission For Two-Drug Regime For HIV Infection By Mid-2025
Merck's DOR/ISL met primary efficacy and safety goals in two Phase 3 HIV trials. Marketing applications are planned for mid-2025.
Diagnostic Kit Maker Illumina To Cut $100 Million In Costs, Lowers 2025 Profit Outlook Amid China Trade Restrictions
Illumina slashes costs by $100 million after China bans its sequencers. The company lowers its 2025 EPS outlook and aims for high-single-digit growth by 2027.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.